| 4th Dec 2018 10:07 am |
RNS |
Director/PDMR Shareholding |
| 3rd Dec 2018 2:00 pm |
RNS |
Total Voting Rights |
| 3rd Dec 2018 12:02 pm |
RNS |
GSK reaches agreement to acquire TESARO |
| 3rd Dec 2018 8:35 am |
RNS |
GSK to divest Horlicks to Unilever |
| 30th Nov 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 30th Nov 2018 4:35 pm |
RNS |
Price Monitoring Extension |
| 29th Nov 2018 3:40 pm |
RNS |
Director/PDMR Shareholding |
| 29th Nov 2018 11:45 am |
RNS |
GSK - Update on Review of Horlicks |
| 27th Nov 2018 3:25 pm |
RNS |
Block listing Interim Review |
| 22nd Nov 2018 1:02 pm |
RNS |
GSK publishes 2019 Dividend Dates |
| 12th Nov 2018 2:45 pm |
RNS |
Director/PDMR Shareholding |
| 12th Nov 2018 9:00 am |
RNS |
Blocklisting Application |
| 8th Nov 2018 12:43 pm |
RNS |
Director Declaration |
| 2nd Nov 2018 4:15 pm |
RNS |
Director/PDMR Shareholding |
| 1st Nov 2018 1:40 pm |
RNS |
Total Voting Rights |
| 31st Oct 2018 2:15 pm |
RNS |
ViiV positive phIII results with fostemsavir |
| 31st Oct 2018 12:07 pm |
RNS |
Second Price Monitoring Extn |
| 31st Oct 2018 12:02 pm |
RNS |
Price Monitoring Extension |
| 31st Oct 2018 12:00 pm |
RNS |
3rd Quarter Results |
| 30th Oct 2018 2:30 pm |
RNS |
ViiV: positive data for long-acting injectable |
| 29th Oct 2018 10:00 am |
RNS |
ViiV - three-year data for long-acting injectable |
| 18th Oct 2018 4:00 pm |
RNS |
ViiV submits HIV 2DR regulatory application to FDA |
| 18th Oct 2018 9:34 am |
RNS |
Director/PDMR Shareholding |
| 17th Oct 2018 5:56 pm |
RNS |
Director/PDMR Shareholding |
| 17th Oct 2018 5:50 pm |
RNS |
Director/PDMR Shareholding |
| 17th Oct 2018 11:30 am |
RNS |
Director/PDMR Shareholding |
| 16th Oct 2018 4:53 pm |
RNS |
Director/PDMR Shareholding |
| 16th Oct 2018 9:30 am |
RNS |
Director/PDMR Shareholding |
| 16th Oct 2018 9:30 am |
RNS |
Director/PDMR Shareholding |
| 10th Oct 2018 3:30 pm |
RNS |
Director/PDMR Shareholding |
| 1st Oct 2018 1:58 pm |
RNS |
Total Voting Rights |
| 27th Sep 2018 4:35 pm |
RNS |
Director/PDMR Shareholding |
| 21st Sep 2018 12:30 pm |
RNS |
CHMP recommends expansion of Trelegy COPD label |
| 14th Sep 2018 9:00 am |
RNS |
ViiV submits HIV 2DR regulatory application to EMA |
| 12th Sep 2018 5:43 pm |
RNS |
Director/PDMR Shareholding |
| 10th Sep 2018 8:00 am |
RNS |
New analysis on efficacy of anti-IL5 biologics SEA |
| 10th Sep 2018 7:00 am |
RNS |
GSK receives CRL from FDA for mepolizumab in COPD |
| 7th Sep 2018 2:24 pm |
RNS |
Director/PDMR Shareholding |
| 7th Sep 2018 2:18 pm |
RNS |
Director/PDMR Shareholding |
| 3rd Sep 2018 5:00 pm |
RNS |
Total Voting Rights |
